Introduction {#sec0005}
============

Iron deficiency anemia (IDA) is the most common type of nutritional anemia in the world; it significantly affects individuals of all ages and economic groups in both developing and developed countries with very staggering international estimates. The World Health Organization (WHO) believes that about one-third of the world\'s population (more than 2 billion people) is anemic, mostly due to iron deficiency.[@bib0005], [@bib0010] Despite worldwide economic and scientific development together with the international efforts and campaigns to combat the prevalence of IDA, there has been little impact on the worldwide prevalence, which remains high and challenging. The WHO reports more troubling prevalences of IDA in developing countries showing that one in every two pregnant woman and 30--40% of preschool children are likely to be anemic, mainly due to iron deficiency.[@bib0015] In Palestine, IDA is recognized as an important health problem and different studies involving different age groups and both genders have underscored the magnitude of IDA as a major public health challenge for improving the health status especially in refugee camps and among vulnerable at-risk groups.[@bib0020], [@bib0025], [@bib0030], [@bib0035] The consequences of anemia are not limited to poor pregnancy outcomes, impaired physical and cognitive development, and increased risk of morbidity in children[@bib0040], [@bib0045], [@bib0050] but affect national productivity and economics.[@bib0055], [@bib0060], [@bib0065]

Vitamin B~12~ deficiency, which is common in wealthier countries, principally among the elderly, is even more prevalent in poorer populations worldwide.[@bib0070] Hyperhomocysteinemia, an elevated circulating total homocysteine concentration, is influenced by genetic and dietary factors such as deficiencies of the enzymes or vitamin cofactors in the homocysteine metabolic pathway.[@bib0075] Hyperhomocysteinemia is a strong and independent risk factor for coronary atherosclerosis and cerebrovascular disorders and strokes.[@bib0080] Hyperhomocysteinemia could be attributed to low concentrations of vitamin B~12~.[@bib0085], [@bib0090], [@bib0095] Moreover, hyperhomocysteinemia and/or low folate and vitamin B~12~ concentrations are potential risk factors for poor pregnancy outcomes and neurocognitive performance.[@bib0085], [@bib0100], [@bib0105]

The aim of the present work was to assess homocysteine and vitamin B~12~ status in female university students with iron deficiency anemia aged 18--22 years from the Gaza Strip. To the best of our knowledge, after searching published scientific works, the present work could be the first that directly investigates the association between the levels of body iron, vitamin B~12~ and homocysteine.

Methods {#sec0010}
=======

The present cross-sectional descriptive study enrolled 240 randomly selected female students, between 18 and 22 years old, in the Islamic university in Gaza. The sample size was calculated for a level of precision of ±7% and a 95% confidence level.[@bib0110] According to these calculations at least 200 female students should be included; this number was increased to 240. About 5 mL of venous blood \[2.5 mL in K~3~ ethylenediaminetetraacetic acid (EDTA) tubes and 2.5 mL in serum tubes\] were collected from each subject to perform a complete blood count (CBC) using a Sysmex XE-2100 hematology analyzer, and to determine the levels of vitamin B~12~, serum ferritin, and serum homocysteine using commercially available kits. Anthropometric characteristics were measured and body mass index was calculated.

Descriptive statistics, frequencies, central tendencies, and statistical analysis tests such as *t*-test and analysis of variance test (ANOVA) were used to clarify the relationship between the research variables. The IBM SPSS software (version 18, IBM Corporation, Somers, NY) was used in the statistical analysis.

Results {#sec0015}
=======

The present study comprised 240 female university students aged 18--22 years. Complete blood count analysis revealed microcytic red blood cells (RBCs) with a mean corpuscular volume (MCV) \<80 fl in 30.0% (72/240) of the screened subjects. On assessing iron stores using the serum ferritin test, 20.4% (49/240) of all screened females had low levels concomitant to reduced hemoglobin (Hb \<12 g/dL) and thus were suffering from iron deficiency anemia while 9.6% (23/240) were microcytic but with normal iron stores. The subjects of this study were categorized into three groups: iron deficiency anemia (*n* = 49), microcytic with normal serum ferritin (*n* = 23), and 20 normocytic non-anemic female students (MCV = 80--96 fl; Hb ≥12.0 g/dL) who were randomly selected as a normal control group. The age and anthropometric characteristics of the study subjects are presented in [Table 1](#tbl0005){ref-type="table"} which shows no significant differences in the mean age and weight of the students in the three groups, while females of the iron deficiency anemia group were shorter than the females in the other groups.

The serum levels of ferritin, vitamin B~12~ and homocysteine of the different groups are shown in [Table 2](#tbl0010){ref-type="table"}. Apart from the significant reduction of serum ferritin, females in the IDA group had significantly lower levels of vitamin B~12~ and significantly higher levels of homocysteine compared to the other two groups. The decrements in vitamin B~12~ and increments in homocysteine of the IDA group were 25.8% and 74.8%, respectively compared to the control group.

The CBC analysis revealed significantly lower values except for the platelet count in IDA subjects compared to the control group ([Table 3](#tbl0015){ref-type="table"}). The mean reductions in hemoglobin and hematocrit (Hct) levels in the IDA group were 15.5% and 9.7%, respectively compared to controls. Some significant differences were also reported between IDA subjects and the microcytic anemia with normal ferritin group.

Analyses using the Pearson correlation coefficient revealed a significant correlation between the serum homocysteine level and other hematological and biochemical parameters as shown in [Table 4](#tbl0020){ref-type="table"}. Among these important correlations are the negative correlation of homocysteine with vitamin B~12~ and the IDA biomarkers such as serum ferritin, hemoglobin and hematocrit ([Figure 1](#fig0005){ref-type="fig"}).

Discussion {#sec0020}
==========

Nutritional deficiencies are very significant to the overall health of humans at all ages and for both genders, however in some age groups (infants and children, and women of childbearing age) these deficiencies can be graver and then the growth and development may be seriously hindered by shortages of essential vitamins or nutrients.[@bib0115] IDA, characterized by microcytic RBC, is the commonest nutritional anemia worldwide affecting people in developing as well as developed countries.[@bib0055] Although vitamin B~12~ deficiency is common in rich countries, particularly among the elderly, it is much more widespread in poorer populations around the world.[@bib0070] Moreover, several scientific reports have associated hyperhomocysteinemia with different medical conditions and nutritional deficiencies.[@bib0080] To the best of our knowledge this work may be the first that directly investigates the association between the levels of body iron, vitamin B~12~ and homocysteine.

The present work enrolled 240 female university students aged 18--22 years, and found a considerable percentage (20.4%) of anemic cases due to IDA which is almost three-fold the percentage (7.0%) reported by Sirdah et al. for the same age group and in the same city 11 years ago.[@bib0020] The higher prevalence of IDA today could be due to a drop in socioeconomic status related to the local political climate and restrictions that have seriously affected the economics of the Gaza Strip over the last seven years.[@bib0030], [@bib0120] Additionally, another fraction (9.6%) of study subjects were found to have microcytic anemia with normal iron stores possibly caused by genetic factors.[@bib0125]

A very interesting finding of the present study is the significantly increased homocysteine levels found in IDA cases compared to the other study groups: 74.5% and 49.2% higher than control and microcytic groups, respectively. It is worthwhile to mention that it seems that no previous studies have directly investigated the homocysteine level in IDA, but hyperhomocysteinemia has been reported in anemic cases due to hereditary factors[@bib0130] and in vegetarians, particularly among vegans.[@bib0135] Elevated homocysteine levels had been found to be associated with low hemoglobin levels in the elderly (85 years old).[@bib0080] Unfortunately iron levels were not determined in these elderly individuals, and then the etiology of anemia could be different. The present study revealed a low level of vitamin B~12~ in IDA subjects. It is not uncommon to find iron deficiency associated with vitamin B~12~ deficiency or other nutritional deficiencies. However, the combined iron and vitamin B~12~ deficiencies could aggravate the clinical condition.[@bib0140], [@bib0145]

Significant correlations were found between serum homocysteine levels on one hand and different blood parameters and indices on the other. This study reports on significant correlations between homocysteine and biomarkers of IDA (Hb, Hct, serum ferritin); unluckily no published study investigated these correlations, thus, further large scale investigations should be performed to evaluate the correlations at different IDA stages and in different risk groups. Nasri and Baradaran reported a positive correlation of homocysteine with Hb and Hct in Pakistani hemodialyzed anemic patients with end-stage renal disease, however these patients had high iron stores.[@bib0150]

The significant correlations between the serum levels of homocysteine, serum ferritin, and vitamin B~12~ in the present study are very clear and stress the need for future studies with in-depth investigations to identify any associations related to the clinical picture not only of microcytic cases but related to other hematological disorders. The significant inverse correlation (*r* = −0.592; *p*-value = 0.001) reported here between serum homocysteine and serum ferritin levels was not reported before in any studies. The association between elevated homocysteine levels and reduced free vitamin B~12~ was previously reported by Miller et al., who assumed this elevation was an early marker for the development of vitamin B~12~ deficiency.[@bib0155] The significant inverse correlation between serum homocysteine and vitamin B~12~ reported in this study is concomitant to what has been published previously.[@bib0160], [@bib0165], [@bib0170]

Although this study found significant associations between different variables, as with all cross-sectional descriptive designs, direct evidence of a temporal relationship between exposure and outcome is generally not provided; this should be considered a primary limitation of all cross-sectional descriptive designs.[@bib0175]

Conclusion {#sec0025}
==========

Iron deficiency anemia is a serious health problem among females of childbearing age, with the prevalence of IDA being almost three-fold higher in this study than in one with a similar population of the same region 11 years ago. Increased homocysteine levels are associated with serum ferritin, IDA biomarkers and vitamin B~12~, and so monitoring homocysteine levels might be essential to understand the development of different clinical conditions including anemia. It is highly recommended to start a national intervention program to screen females of childbearing age for IDA, especially secondary school and university students and consequently correct anemia by replenishing body iron stores. Further studies should be conducted to identify any correlations of serum homocysteine as a biomarker of the early stages of iron deficiency in different high-risk IDA groups and to determine whether treating anemia ameliorates the homocysteine level.
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###### 

Age and anthropometric measurements of the study subjects.

  Anthropometric measurements   IDA (*n* = 49)   Microcytic normal ferritin (*n* = 23)   Normal control (normocytic) (*n* = 20)   *P*-value[a](#tblfn0005){ref-type="table-fn"}
  ----------------------------- ---------------- --------------------------------------- ---------------------------------------- -----------------------------------------------
  Age                           19.6 ± 1.3       20.1 ± 1.5                              20.0 ± 1.7                               0.369
  Weight (kg)                   59.0 ± 8.5       60.4 ± 9.9                              59.2 ± 12.2                              0.842
  Height (cm)                   159.6 ± 4.7      164.0 ± 5.9                             161.7 ± 5.9                              0.006
  Body mass index               23.1 ± 3.0       22.4 ± 3.5                              22.5 ± 4.2                               0.674

IDA, iron deficiency anemia; SD, standard deviation.

ANOVA.

###### 

Serum ferritin, vitamin B~12~ and homocysteine levels of the different study groups.

  Biochemical analysis     IDA (*n* = 49)   Microcytic normal ferritin (*n* = 23)   Normal control (normocytic) (*n* = 20)   *P*-value
  ------------------------ ---------------- --------------------------------------- ---------------------------------------- ---------------------------------------------
  Serum ferritin (ng/mL)   5.1 ± 2.7        25.1 ± 10.5                             NA                                       \<0.001[a](#tblfn0010){ref-type="table-fn"}
  Vitamin B~12~ (pg/mL)    212.9 ± 62.7     256.7 ± 71.1                            286.9 ± 57.1                             \<0.001[b](#tblfn0015){ref-type="table-fn"}
  Homocysteine (μmol/L)    27.0 ± 4.6       18.1 ± 2.7                              15.45 ± 2.9                              \<0.001[b](#tblfn0015){ref-type="table-fn"}

IDA, Iron deficiency anemia; NA, Not available; SD, Standard deviation.

Independent *t*-test.

ANOVA.

###### 

Hematological parameters of the study subjects.

  Hematological parameter   IDA (*n* = 49)   Microcytic normal ferritin (*n* = 23)   Normal control (*n* = 20)   *P*-value[a](#tblfn0020){ref-type="table-fn"}
  ------------------------- ---------------- --------------------------------------- --------------------------- -----------------------------------------------
  WBC (× 10^9^ L^--1^)      6.53 ± 1.98      7.73 ± 1.82                             8.07 ± 2.1                  0.005
  RBC (× 10^12^ L^--1^)     4.45 ± 0.39      4.56 ± 0.41                             4.72 ± 0.36                 0.015
  Hb (g/dL)                 10.5 ± 1.13      11.5 ± 1.49                             12.42 ± 0.99                \<0.001
  Hct (%)                   32.4 ± 2.4       34.4 ± 3.0                              35.9 ± 2.4                  \<0.001
  MCV (fl)                  73.1 ± 5.4       75.1 ± 5.5                              84.8 ± 3.8                  \<0.001
  MCH (pg)                  23.8 ± 2.8       25.1 ± 3.1                              29.3 ± 1.1                  \<0.001
  MCHC (g/dL)               32.4 ± 1.9       33.1 ± 2.2                              34.6 ± 0.91                 \<0.001
  PLT (× 10^9^ L^--1^)      280.2 ± 70.6     307.0 ± 75.3                            310.1 ± 45.2                0.137

IDA, iron deficiency anemia; WBC, white blood cell count; RBC, red blood cell count; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelet count; SD, standard deviation.

ANOVA.

###### 

Homocysteine level in relation to serum ferritin of the study population.

                           Homocysteine (μmol/L)   
  ------------------------ ----------------------- -------
  Serum ferritin (ng/mL)   −0.592                  0.000
  Vitamin B~12~ (pg/mL)    −0.361                  0.000
  WBC (× 10^9^ L^−1^)      −0.262                  0.012
  RBC (× 10^12^ L^−1^)     0.038                   0.720
  Hb (g/dL)                −0.364                  0.000
  Hct (%)                  −0.337                  0.001
  MCV (fl)                 −0.352                  0.001
  MCH (pg)                 −0.359                  0.000
  MCHC (g/dL)              −0.248                  0.017
  PLT (× 10^9^ L^−1^)      −0.178                  0.090

WBC, white blood cell count; RBC, red blood cell count; Hb, hemoglobin; Hct, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; and PLT, platelet count.

ANOVA.
